Brazil Diagnostic Imaging Equipment Market Size and Share

Brazil Diagnostic Imaging Equipment Market (2026 - 2031)
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.
View Global Report

Brazil Diagnostic Imaging Equipment Market Analysis by 麻豆视频

The Brazil Diagnostic Imaging Equipment Market size is expected to grow from USD 1.31 billion in 2025 to USD 1.38 billion in 2026 and is forecast to reach USD 1.82 billion by 2031 at 5.58% CAGR over 2026-2031.

The healthcare market is undergoing a significant transformation, driven by the shift toward high-complexity modalities, an aging installed base in public hospitals, and ANVISA鈥檚 pro-innovation reforms. Private hospital chains and diagnostic networks are expediting procurement processes to comply with federal mandates for faster oncology and stroke diagnostics. Simultaneously, municipal entities are preparing to capitalize on the September 2025 procurement reform, which will enable direct equipment purchases. The rapid adoption of teleradiology is facilitating the deployment of mobile ultrasound and X-ray units in underserved interior regions. Furthermore, AI-enabled software retrofits are extending the operational lifespan of older CT and MRI scanners. Local manufacturing incentives, such as Rota 2030 and PADIS, are helping global vendors mitigate import tariffs, ensuring stable unit sales despite currency fluctuations.

Key Report Takeaways

  • By modality, X-ray systems led with 22.05% of the Brazil diagnostic imaging equipment market share in 2025, while MRI is advancing at a 7.54% CAGR through 2031.
  • By portability, fixed installations commanded 81.62% of 2025 revenue, whereas mobile and hand-held systems are projected to post a 7.86% CAGR to 2031.
  • By application, oncology accounted for 26.76% of overall spending in 2025; neurology imaging is forecast to expand at a 8.21% CAGR during 2026-2031.
  • By end-user, hospitals accounted for 58.54% of total sales in 2025, yet diagnostic imaging centers are on track for a faster 6.54% CAGR through 2031.

Note: Market size and forecast figures in this report are generated using 麻豆视频鈥檚 proprietary estimation framework, updated with the latest available data and insights as of 2026.

Segment Analysis

By Modality: MRI鈥檚 Rapid Ascendancy in Oncology Protocols

In 2025, X-ray captured a 22.05% share of Brazil's diagnostic imaging equipment market, reinforcing its critical role in emergency departments. Meanwhile, MRI is projected to achieve a 7.54% CAGR through 2031, representing the fastest growth within Brazil's diagnostic imaging market. The increasing prevalence of oncology cases and rising neurology workloads are driving the adoption of AI-enabled 1.5 T and 3 T systems, which significantly enhance efficiency by reducing scan times. Hospitals are increasingly adopting helium-free magnets, such as the ECHELON Smart platform, citing benefits like lower lifecycle costs and improved supply-chain resilience in remote areas. While CT maintains a large installed base, over 66% of its units are more than six years old. Consequently, many facilities are implementing dose-optimization software like SubtleHD鈩 instead of investing in new scanners. Ultrasound continues to dominate obstetrics and rural care, supported by battery-powered Mindray models that enable seamless image uploads when connectivity is available. Although nuclear medicine remains a niche segment, it is highly profitable; for example, United Imaging鈥檚 total-body PET/CT at the Portuguese Charity of S茫o Paulo delivers unmatched oncology throughput compared to partial-body systems.

The growing prominence of MRI is reshaping procurement strategies. Rede D'Or's deployment of sealed magnets highlights the willingness of private healthcare chains to invest in advanced technology that minimizes downtime and mitigates helium supply risks. Compliance with Law 12.732/2012, which mandates timely malignancy confirmation, is driving hospitals to rely on multiparametric MRI for precise biopsy planning. X-ray manufacturers are differentiating their offerings with dose-tracking dashboards that meet the stringent IEC 60601-2-54 standard, a key requirement in municipal tenders. CT vendors are partnering with AI firms to introduce retrofits that reduce radiation exposure by up to 40% while extending the lifespan of existing assets, a critical advantage for budget-constrained SUS hospitals. Mammography vendors are addressing the market's low penetration rate by offering turnkey screening solutions funded through public-private partnerships. As a result, the market is shifting towards high-field MRI and AI-enhanced CT, while value-tier mobile X-ray and ultrasound systems continue to sustain unit volumes in primary care settings.

Brazil Diagnostic Imaging Equipment Market: Market Share by Modality
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.
Brazil Diagnostic Imaging Equipment Market: Market Share by Modality

By Portability: Mobile Systems Extend Care Beyond Megacities

In Brazil's diagnostic imaging equipment market, hospital-based imaging hubs dominated, contributing 81.62% of the revenue in 2025. However, with the increasing adoption of teleradiology, mobile and handheld units are projected to grow at a CAGR of 7.86% through 2031. Rural municipalities in the North, constrained by limited road infrastructure, rely on riverboats and aeromedical teams equipped with battery-powered ultrasound and X-ray devices. A study conducted in the Legal Amazon demonstrated the effectiveness of portable scanners, showing that equipping medevac helicopters expanded emergency service coverage to 71% of the population from nine operational bases. As a result, the mobile platform segment within Brazil's diagnostic imaging market is expected to witness the fastest growth in the North and Northeast, where workforce and infrastructure gaps are most pronounced.

Urban hospitals are also shifting toward mobility for bedside imaging, optimizing the utilization of fixed CT and MRI suites. The New Development Bank's "Smart Hospital" initiative incorporates Wi-Fi-enabled imaging carts for remote wards, enabling radiologists to analyze scans without relocating fragile patients. Vendors such as Fujifilm are leveraging INMETRO-certified lithium batteries that provide full-shift power while adhering to infection-control standards by eliminating power cables. Additionally, AI-enabled edge processing integrated into probes now delivers preliminary interpretations, reducing the workload on the limited pool of specialists. With private insurers reimbursing portable scans at rates comparable to fixed-site imaging, the adoption of mobile solutions is further incentivized. Consequently, the demand for portable imaging solutions is expanding from remote river docks to advanced tertiary ICUs, creating a new layer of growth alongside the established dominance of fixed-site imaging.

By Application: Oncology Leadership Reflects Disease Burden

In 2025, oncology accounted for 26.76% of total spending, maintaining its dominant position. However, neurology is projected to experience the fastest growth, with an 8.21% CAGR through 2031, as Brazil focuses on addressing its stroke-care gap. Thrombolysis usage remains below 1% across 394 health regions, prompting federal authorities to allocate funds for CT and MRI units capable of executing stroke protocols within the therapeutic window. Bracco鈥檚 AiMIFY鈩 software, which received ANVISA clearance in November 2025, enhances lesion-contrast sensitivity, a development that physicians regard as critical for accelerating ischemia mapping. Cardiology is leveraging DASA鈥檚 extensive network of 521 facilities to standardize cardiac CT angiography, while orthopedics increasingly relies on MRI for cartilage assessments to meet the needs of an aging population. Obstetrics is also expanding, driven by the adoption of handheld ultrasound devices that reduce barriers to prenatal care.

Oncology鈥檚 leadership is underpinned by INCA鈥檚 cancer incidence forecasts and the statutory 60-day treatment rule, which mandates capacity expansion even in budget-constrained public healthcare centers. PET/CT upgrades are eligible for PADIS tax incentives if vendors incorporate local content, directing demand toward manufacturers with Brazilian assembly operations. Neurology鈥檚 robust growth is fueled by the Ministry of Health鈥檚 efforts to reduce the 2.3 million disability-adjusted life years lost to strokes in 2025. Diagnostic chains are strategically positioning neurology suites near emergency departments to capture time-sensitive referrals. Additionally, AI-enhanced MRI technology is gradually entering the dementia screening market, which holds significant potential given Brazil鈥檚 forecast of 5.1 million Alzheimer鈥檚 patients by 2035. While oncology continues to lead in revenue, neurology is emerging as the key growth driver in Brazil鈥檚 diagnostic imaging equipment market.

Brazil Diagnostic Imaging Equipment Market: Market Share by Application
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.
Brazil Diagnostic Imaging Equipment Market: Market Share by Application

By End-User: Diagnostic Centers Accelerate on Vertical Integration

In Brazil's diagnostic imaging equipment market, hospitals accounted for 58.54% of expenditures in 2025. However, diagnostic imaging centers are projected to grow at a 6.54% CAGR, outpacing the growth of inpatient facilities. Rede D'Or鈥檚 acquisition of Richet highlights a strategic move, as chains increasingly integrate outpatient scanners into hospital operations to capture a larger share of imaging revenues. DASA, managing over 200 million exams annually鈥35% of which are imaging鈥攍everages its scale to negotiate bulk discounts on multi-scanner roll-outs, effectively reducing per-scan costs. Diagnostic centers, with streamlined compliance procedures, are adopting AI software like Philips鈥 chest-X-ray algorithm suite at a faster pace. Meanwhile, specialty clinics, though smaller in scale, cater to affluent urban patients who pay cash for immediate services such as breast MRIs or musculoskeletal scans.

Hospitals remain critical for emergency and interventional imaging, with initiatives like the Smart Hospital project set to strengthen S茫o Paulo鈥檚 public network. This project will add 800 beds and advanced imaging modalities, integrating AI scheduling with tele-ICU coverage. The September 2025 procurement reform granted SUS entities greater flexibility, but limited federal transfers to capital budgets continue to constrain public hospitals, forcing many to rely on leasing or vendor credit for scanner financing. In contrast, diagnostic centers are leveraging private equity and insurer partnerships to expand capacity beyond the limitations of public budgets. Specialty clinics are thriving by offering personalized care; for example, breast centers combine mammography, ultrasound, and MRI services under one roof, utilizing compact equipment suited to their limited space. While hospitals retain their position as revenue leaders, outpatient chains are driving the fastest growth in Brazil's diagnostic imaging equipment market.

Regulatory Landscape

Brazil regulates diagnostic imaging equipment as medical devices under ANVISA, with risk classification and market access pathways defined in RDC 751/2022 (notification for lower-risk classes and registration for higher-risk classes). For imaging systems and related software, suppliers also need to meet specific requirements for SaMD and electromedical safety conformity, including INMETRO certification expectations for electrical medical equipment and alignment to ABNT NBR IEC 60601-series standards.

Modality-specific sanitary requirements also apply, with ANVISA Normative Instructions covering MRI (IN No. 97/2021) and CT (IN No. 93/2021), in addition to service-level requirements for radiology operations. In trade policy, import cost volatility became a more visible factor in early 2026 after GECEX issued Resolution 852/2026, adjusting tariffs across a broad set of items that include medical devices. A temporary, time-bound relief mechanism via Resolution 853/2026 was then introduced for selected affected items, which increases the importance of local assembly, remanufacturing, and exemption planning for high-value imaging modalities.

Value Chain Analysis

The value chain typically starts with global component and subsystem suppliers (detectors, tubes, coils, generators, and computing) that feed into OEM manufacturing and final assembly. In Brazil, importers, distributors, and service organizations then manage installation, acceptance testing, and multi-year maintenance contracts. The supply structure remains hybrid, combining imports with localized operations, including local manufacturing presence (for example, Canon Medical Systems in Campinas, Sao Paulo) and remanufacturing/refurbishment activity to extend asset life for price-sensitive buyers.

Downstream, distributors and service partners carry outsized influence because uptime, parts availability, and compliance documentation are central to buyer decisions, especially for CT and MRI where lifecycle cost is scrutinized. Imaging providers (hospital chains, diagnostic networks, and PPP operators serving SUS) are increasingly procuring bundled offerings that combine equipment with PACS, connectivity, and remote reading workflows. Regulatory and operating requirements for radiology services, such as RDC 611/2022, and INMETRO-aligned electrical safety expectations shape commissioning processes and recurring QA activities. Logistics constraints into the North and interior regions, along with uneven connectivity for teleradiology, also affects modality mix, supporting demand for mobile, battery-capable ultrasound and X-ray alongside hub-and-spoke deployment models.

Competitive Landscape

The diagnostic imaging equipment market in Brazil is moderately concentrated, with key players such as GE Healthcare, Siemens Healthineers, and Philips leveraging localized production under Rota 2030 to avoid high import tariffs. GE operates a remanufacturing facility in Contagem, extending the lifecycle of X-ray and mammography equipment to cater to cost-sensitive public sector buyers. Siemens utilizes PADIS credits to ensure rapid delivery of CT scanners from its Joinville logistics hub, guaranteeing shipment to any Southeast client within 48 hours. Philips strengthens customer retention by offering multi-year AI and PACS subscription packages, which combine software updates with hardware refresh cycles, effectively increasing switching costs.

Chinese competitors, including United Imaging and Mindray, are disrupting price points by importing sub-assemblies for final testing in S茫o Paulo's free-trade zones. United Imaging鈥檚 subsidiary, launched in July 2025, introduced total-body PET/CT systems capable of completing full-body scans in under 20 minutes, addressing the needs of high-volume oncology centers. Mindray, with a 16-year presence in the region, reports its ultrasound systems are installed in 80% of Latin American medical institutions, with sales increasing by 25% year-on-year in 2024. Canon Medical and Fujifilm compete in helium-free MRI and enterprise imaging IT, respectively, while Esaote and Neusoft focus on niche segments such as low-field MRI and compact CT systems.

Market players are transitioning from unit sales to lifetime-value business models. Siemens, through a February 2025 partnership with Galileu Health, has integrated cloud teleradiology services in rural S茫o Paulo, enabling revenue generation through per-study billing. Philips, via its Vue-Carpl.ai integration, offers algorithm-as-a-service, tying customers to annual licenses indexed to exam volumes. Regulatory advancements, such as ANVISA鈥檚 AnvisAI fast-track, have reduced software approval timelines from 180 days to under 90 for compliant dossiers, favoring companies with robust regulatory capabilities and creating challenges for smaller AI startups. Additionally, the anticipated passage of Bill 2,338/2023, which aims to codify algorithm liability, is expected to consolidate market power among the top six vendors capable of managing associated legal costs.

Brazil Diagnostic Imaging Equipment Industry Leaders

  1. GE Healthcare

  2. Siemens Healthineers

  3. Koninklijke Philips N.V.

  4. Canon Medical Systems

  5. Fujifilm Holdings Corp.

  6. *Disclaimer: Major Players sorted in no particular order
Brazil Diagnostic Imaging Equipment Market Concentration
Image 漏 麻豆视频. Reuse requires attribution under CC BY 4.0.

Market Opportunities and Future Outlook

Public-sector modernization and more standardized acquisition planning are creating clearer procurement lanes for vendors that can package imaging hardware together with installation, lifecycle service, and digital integration. In June 2026, the Ministry of Health launched guidelines for a national plan to modernize the SUS medical equipment park and reduce diagnostic wait times, while Portaria GM/MS 11.694/2026 mandated Technical Preliminary Studies (ETP) for diagnostic equipment acquisitions to address sustainability, maintenance, and technical compliance. This is shifting opportunity toward suppliers that can document total cost of ownership, demonstrate local service capacity, and support interoperability, including PACS and connectivity to national data infrastructure.

A second opportunity is faster deployment through PPPs and network-led rollouts beyond major capitals, using established implementations as templates. In March 2026, Philips installed a CT 5300 at Hospital Estadual do Litoral Norte (Bahia) through a partnership with Rede Brasileira de Diagnostico (RBD Imagem), showing how vendors can attach advanced CT to service delivery models within the SUS pathway. At the same time, early-2026 tariff adjustments increased the value of localization strategies, including assembly, refurbishment, and compliant substitution planning, for import-heavy modalities such as CT, MRI, and PET/CT. This supports vendors and channel partners seeking to stabilize lead times and pricing while keeping ANVISA and INMETRO compliance artifacts audit-ready.

Recent Industry Developments

  • June 2026: Siemens Healthineers initiated a partnership with Grupo Elfa, positioning Elfa as a master dealer in Brazil with a focus on expanding ultrasound distribution, including systems such as the ACUSON Maple. The partnership improves last-mile logistics and commercial coverage for point-of-care and departmental ultrasound, where tenders and private-network rollouts depend on fast delivery and service reach.
  • April 2026: Philips announced the launch of a web-based version of Vue PACS for Latin America at JPR 2026. This adds a lighter-deployment enterprise imaging option for multi-site diagnostic networks and teleradiology workflows, supporting hardware refresh and retrofit strategies tied to subscription software.
  • November 2025: Bracco Imaging secured ANVISA clearance for AiMIFY, an AI-enabled MRI brain package used in stroke and dementia protocols. The approval broadened the set of regulated AI add-ons available for installed MRI systems, reinforcing the shift toward software-led throughput and diagnostic performance improvements without immediate magnet replacement.

Table of Contents for Brazil Diagnostic Imaging Equipment Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope Of The Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic and Lifestyle Diseases
    • 4.2.2 Accelerating Population Aging and Imaging Utilization
    • 4.2.3 Ongoing Digital Transformation and Modalities Upgrade Cycles
    • 4.2.4 Expanding Public-Private Healthcare Investment Programs
    • 4.2.5 Rapid Growth of Teleradiology Start-Ups Enabling Rural Market Penetration
    • 4.2.6 Local Manufacturing Incentives Under Brazil鈥檚 Rota 2030 And PADIS Programs
  • 4.3 Market Restraints
    • 4.3.1 High Capital Expenditure and Total Cost of Ownership
    • 4.3.2 Shortage of Skilled Radiology Workforce
    • 4.3.3 Persistent Logistics Bottlenecks in Northern & Interior Regions
    • 4.3.4 Regulatory Approval Delays for AI-Enabled Imaging Software
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Outlook
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat Of New Entrants
    • 4.7.2 Bargaining Power Of Buyers
    • 4.7.3 Bargaining Power Of Suppliers
    • 4.7.4 Threat Of Substitutes
    • 4.7.5 Intensity Of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Modality
    • 5.1.1 X-Ray
    • 5.1.2 Ultrasound
    • 5.1.3 Computed Tomography
    • 5.1.4 MRI
    • 5.1.5 Nuclear Imaging (PET/SPECT)
    • 5.1.6 Fluoroscopy & C-Arms
    • 5.1.7 Mammography
  • 5.2 By Portability
    • 5.2.1 Fixed Systems
    • 5.2.2 Mobile & Hand-Held Systems
  • 5.3 By Application
    • 5.3.1 Oncology
    • 5.3.2 Cardiology
    • 5.3.3 Neurology
    • 5.3.4 Orthopedics
    • 5.3.5 Obstetrics & Gynecology
    • 5.3.6 Other Applications
  • 5.4 By End-User
    • 5.4.1 Hospitals
    • 5.4.2 Diagnostic Imaging Centers
    • 5.4.3 Specialty Clinics

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles {(Includes Global Level Overview, Market Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)}
    • 6.3.1 Agfa-Gevaert Group
    • 6.3.2 Canon Medical Systems
    • 6.3.3 Carestream Health
    • 6.3.4 Esaote SpA
    • 6.3.5 Fujifilm Holdings Corp.
    • 6.3.6 GE Healthcare
    • 6.3.7 Hologic Inc.
    • 6.3.8 Konica Minolta Healthcare
    • 6.3.9 Koninklijke Philips N.V.
    • 6.3.10 Neusoft Medical Systems Co., Ltd.
    • 6.3.11 Samsung Healthcare
    • 6.3.12 Shimadzu Corp.
    • 6.3.13 Siemens Healthineers
    • 6.3.14 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 6.3.15 United Imaging Healthcare

7. Market Opportunities & Future Outlook

  • 7.1 White-Space & Unmet-Need Assessment

Research Methodology Framework and Report Scope

Market Definition and Coverage

This market covers revenue generated from diagnostic imaging equipment sold and installed in Brazil for clinical imaging, across both fixed and mobile configurations, and counted in value terms for the equipment market.

Scope exclusions: We exclude imaging service revenue, contrast agents, and routine maintenance-only contracts that are not bundled with equipment sales.

Segmentation Overview

  • By Modality
    • X-Ray
    • Ultrasound
    • Computed Tomography
    • MRI
    • Nuclear Imaging (PET/SPECT)
    • Fluoroscopy & C-Arms
    • Mammography
  • By Portability
    • Fixed Systems
    • Mobile & Hand-Held Systems
  • By Application
    • Oncology
    • Cardiology
    • Neurology
    • Orthopedics
    • Obstetrics & Gynecology
    • Other Applications
  • By End-User
    • Hospitals
    • Diagnostic Imaging Centers
    • Specialty Clinics

Data Sources, Market Sizing, and Validation

Desk Research

We first mapped the demand context for imaging equipment in Brazil using public signals that are stable year to year, then used them as sanity checks for the model. Key sources included Brazil Ministry of Health materials (including DATASUS), ANVISA device and regulatory information, and IBGE demographic and macro series, plus foreign trade statistics from Comex Stat to validate equipment inflows and the direction of pricing.

To ground the sizing inputs, we also reviewed manufacturer public materials such as product catalogs, investor presentations, and local distributor announcements, along with peer-reviewed radiology and health economics publications that describe modality utilization and replacement cycles. Where helpful, we referenced paid subscriptions for company financials and for patent tracking to cross-check activity trends and product cycles without relying on a single dataset. The desk sources listed here are illustrative, and we reviewed many other public documents and datasets for data collection, validation, and clarification.

Primary Interviews and Surveys

Primary work was used to pressure-test assumptions that desk research cannot reliably confirm, especially around purchasing behavior, typical configuration choices, and current replacement timing across Brazil. We spoke with a mix of hospital procurement stakeholders, diagnostic center operators, service partners, and clinical users. Their input was then used to adjust utilization signals and pricing logic feeding into the final model.

Distribution of primary research fieldwork respondents

Company type Respondent position Region
Top tier: 36% CXOs: 15%
Mid tier: 47% Functional/Unit leaders: 34%
Smaller Players: 17% Managers: 51%

Market-Sizing & Forecasting

Sizing was built using a top-down approach once, where Brazil equipment demand was reconstructed from the installed base outlook and expected replacement additions across key imaging modalities, then translated into value using representative price bands. To keep totals realistic, we corroborated results with selective bottom-up approximations, such as sampled ASP times estimated annual unit placements by modality, and cross-checks against the supplier and channel view captured in interviews.

Inputs that mattered in the model included modality-wise installed base direction, replacement cycle lengths by equipment class, procurement mix between public and private settings, typical system configuration splits (fixed versus mobile and hand-held), and price movement assumptions influenced by import share and currency timing. For forecasting, we leaned on scenario analysis supported by a small set of drivers, including procedure volume recovery, budget availability, and replacement deferral behavior. These were reviewed with interview feedback so the trajectory stayed practical. Where bottom-up unit checks were incomplete for smaller purchasers, gaps were handled by applying conservative penetration and refresh-rate assumptions, which were validated through channel conversations.

Data Validation & Update Cycle

Outputs were validated through triangulation across multiple checks, including implied unit volumes versus replacement logic, modality shares versus clinical adoption signals, and year-over-year swings versus import and pricing direction. When variances looked unusual, we revisited the underlying assumptions, and triggered follow-up outreach to confirm whether the change was real or tied to a specific input.

Before sign-off, the model and write-up go through multi-step analyst review so calculations, definitions, and logic remain consistent. Reports are refreshed annually, with interim updates when major policy, procurement, or currency events materially affect pricing or demand. A final pre-delivery pass is completed to ensure clients receive the latest view.

麻豆视频's Brazil Diagnostic Imaging Equipment Market Estimate Compared With Other Published Estimates

It is common to see different market values for diagnostic imaging equipment because publishers do not always count the same products, years, or pricing basis. Some studies use shipment proxies or high-level healthcare spending splits, while others rely more on installed base logic and replacement timing, and these choices shift the final value.

The spread is usually driven by what gets included as equipment, for example whether mobile and hand-held systems are fully counted, how modality mix is treated, and whether values reflect new sales only or also include longer-term bundled packages. Differences also come from base-year selection and currency conversion timing, and from how often assumptions are re-checked with local buyers when procurement conditions change. In the model here, fixed systems and mobile and hand-held are separated in a consistent way, and replacement cycle inputs are re-tested through field validation, which is why the 2025 figure differs for 麻豆视频.

Benchmark comparison

Source Market Size Gaps in Research Methodology
麻豆视频 USD 1.31 B (2025)
Industry Publisher A USD 0.62 B (2025) Uses a narrower value pool that appears to undercount higher-priced modalities and can treat parts of the market as a medical imaging subset, which pulls down the 2025 total even if growth rates are similar.
Market Tracker B USD 1.27 B (2024) Uses a different base year and forecast window, and the sizing is presented at a single national total without clear alignment to modality and portability mix in the base year, which can shift the implied pricing and year-to-year comparability.

Across the three values, the main takeaway is that scope choices and timing choices explain most of the gap, not just forecast optimism. When modality coverage, portability splits, and currency timing are made explicit, the estimate becomes easier to reconcile with demand signals and to update in a repeatable way as new procurement and replacement information comes in.

Key Questions Answered in the Report

What is the projected value of the Brazil diagnostic imaging equipment market by 2031?

It is forecast to reach USD 1.81 billion, growing at a 5.58% CAGR between 2026 and 2031.

Which modality is expected to grow fastest through 2031 in Brazil?

MRI is projected to rise at a 7.54% CAGR, driven by oncology and neurology protocols.

Why are mobile imaging systems gaining popularity in Brazil?

Teleradiology start-ups and rural health programs need portable equipment that works in areas lacking fixed infrastructure and specialist coverage.

How will the new procurement law affect public hospitals?

The September 2025 amendment lets SUS facilities buy scanners directly, freeing them from federal grant delays and possibly speeding up equipment replacement.

Which companies dominate Brazil's diagnostic imaging space?

GE Healthcare, Siemens Healthineers, and Philips hold the largest combined share, with United Imaging and Mindray expanding rapidly.

Page last updated on:

Brazil Diagnostic Imaging Equipment Market Report Snapshots